{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:34:53Z","timestamp":1781195693053,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a severe extra-articular complication of RA, contributing significantly to morbidity and mortality. Despite its impact, the immunological mechanisms driving RA-ILD remain poorly understood. This systematic review and meta-analysis aims to define a distinct immunological signature for RA-ILD and evaluate its associations with demographic, serological, and clinical parameters. Following PRISMA guidelines, we searched PubMed, Scopus, and Web of Science for studies comparing cytokine and chemokine levels in RA-ILD vs. RA patients without ILD. Eligible studies measured these molecules in biological samples and were published in English. Data were extracted on study characteristics, cytokine\/chemokine levels, and clinical, serological, and demographic parameters. Meta-analyses used standardized mean differences for continuous outcomes and risk differences for dichotomous outcomes, with heterogeneity assessed via I2 and Cochran\u2019s Q tests. Narrative synthesis explored correlations due to heterogeneous reporting. From 2000 articles, 15 studies involving 3,433 patients (715 RA-ILD, 2,718 RA-no ILD) were included. RA-ILD patients exhibited elevated levels of six chemokines (CCL2, CCL4, CCL18, CXCL8, CXCL10, SDF-1\u03b1) and 11 cytokines (IL-1\u03b1, IL-4, IL-6, IL-11, IL-13, IL-18, IL-23, IL-33, IL-36\u03b1, IL-36\u03b3, TGF-\u03b2), with reduced IL-22, forming a distinct immunological profile. RA-ILD patients had elevated anti-CCP, CRP, and RF levels, indicating heightened autoimmunity and greater disease activity. Correlations linked IL-13 and TGF-\u03b2 to disease severity, while IL-22 and IL-36\u03b3 showed protective roles. This meta-analysis establishes a pioneering cytokine and chemokine profile distinguishing RA-ILD from RA, offering potential for early diagnosis and monitoring. Complementary demographic, serological, and clinical findings underscore RA-ILD\u2019s distinct pathogenesis.<\/jats:p>","DOI":"10.1186\/s40001-026-04074-9","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T03:36:14Z","timestamp":1772422574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytokine and chemokine profile in rheumatoid arthritis patients with and without interstitial lung disease: a systematic review and meta-analysis integrating demographic, serological, and clinical comparisons"],"prefix":"10.1186","volume":"31","author":[{"given":"Bing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiliang","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"2","key":"4074_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ca.22980","volume":"31","author":"K Sharif","year":"2018","unstructured":"Sharif K, Sharif A, Jumah F, Oskouian R, Tubbs RS. Rheumatoid arthritis in review: clinical, anatomical, cellular and molecular points of view. Clin Anat. 2018;31(2):216\u201323.","journal-title":"Clin Anat"},{"issue":"4","key":"4074_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4081\/reumatismo.2018.1106","volume":"70","author":"V Valentini","year":"2018","unstructured":"Valentini V, Valentini E, La Paglia G, Bonifacio A, Gerli R. Extra-articular rheumatoid arthritis. Reumatismo. 2018;70(4):212\u201324.","journal-title":"Reumatismo"},{"issue":"4","key":"4074_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev. 2021;20(4):102776.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4074_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2332406","volume":"56","author":"H-F Wang","year":"2024","unstructured":"Wang H-F, Wang Y-Y, Li Z-Y, He P-J, Liu S, Li Q-S. The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Ann Med. 2024;56(1):2332406.","journal-title":"Ann Med"},{"key":"4074_CR5","doi-asserted-by":"publisher","first-page":"1542400","DOI":"10.3389\/fmed.2025.1542400","volume":"12","author":"N Bernardinello","year":"2025","unstructured":"Bernardinello N, Zen M, Castelli G, Cocconcelli E, Balestro E, Borie R, et al. Navigating interstitial lung disease associated with rheumatoid arthritis (RA-ILD): from genetics to clinical landscape. Front Med. 2025;12:1542400.","journal-title":"Front Med"},{"issue":"8","key":"4074_CR6","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1093\/rheumatology\/keaa836","volume":"60","author":"JA Sparks","year":"2021","unstructured":"Sparks JA, Jin Y, Cho S-K, Vine S, Desai R, Doyle TJ, et al. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis\u2013associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatology. 2021;60(8):3689\u201398.","journal-title":"Rheumatology"},{"issue":"7","key":"4074_CR7","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/rheumatology\/kead535","volume":"63","author":"JA Poole","year":"2024","unstructured":"Poole JA, England BR, Sayles H, Johnson TM, Duryee MJ, Hunter CD, et al. Serum alarmins and the risk of incident interstitial lung disease in rheumatoid arthritis. Rheumatology. 2024;63(7):1998\u20132005.","journal-title":"Rheumatology"},{"issue":"6","key":"4074_CR8","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina\u2010Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population\u2010based study. Arthritis Rheum. 2010;62(6):1583\u201391.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"4074_CR9","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, L\u00f8kke A, Bendstrup E, et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis. 2017;76(10):1700\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4074_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/1744666X.2021.1905524","volume":"17","author":"A Manfredi","year":"2021","unstructured":"Manfredi A, Cassone G, Luppi F, Atienza-Mateo B, Cavazza A, Sverzellati N, et al. Rheumatoid arthritis related interstitial lung disease. Expert Rev Clin Immunol. 2021;17(5):485\u201397.","journal-title":"Expert Rev Clin Immunol"},{"issue":"9","key":"4074_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.837133","volume":"13","author":"A LA Laria","year":"2022","unstructured":"LA Laria A, Zizzo G, Zaccara E, Mazzocchi D, Re KA, Marrazza M, et al. Interstitial lung disease in rheumatoid arthritis: a practical review. Front Med. 2022;13(9):837133.","journal-title":"Front Med"},{"issue":"10","key":"4074_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41584-019-0275-x","volume":"15","author":"D Wang","year":"2019","unstructured":"Wang D, Zhang J, Lau J, Wang S, Taneja V, Matteson EL, et al. Mechanisms of lung disease development in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15(10):581\u201396.","journal-title":"Nat Rev Rheumatol"},{"issue":"19","key":"4074_CR13","doi-asserted-by":"publisher","first-page":"14509","DOI":"10.3390\/ijms241914509","volume":"24","author":"YYH Kim","year":"2023","unstructured":"Kim YYH, Kim KS. Etiology and pathogenesis of rheumatoid arthritis-interstitial lung disease. Int J Mol Sci. 2023;24(19):14509.","journal-title":"Int J Mol Sci"},{"issue":"74","key":"4074_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105700","volume":"1","author":"CLH Wu","year":"2019","unstructured":"Wu CLH, Zhang X. Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3). Int Immunopharmacol. 2019;1(74):105700.","journal-title":"Int Immunopharmacol"},{"key":"4074_CR15","doi-asserted-by":"publisher","first-page":"1455346","DOI":"10.3389\/fimmu.2024.1455346","volume":"15","author":"LWJ Guo","year":"2024","unstructured":"Guo LWJ, Li J, Yao J, Zhao H. Biomarkers of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Front Immunol. 2024;15:1455346.","journal-title":"Front Immunol"},{"issue":"11","key":"4074_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241719","volume":"15","author":"MOM Kameda","year":"2020","unstructured":"Kameda MOM, Chiba H, Kuronuma K, Hasegawa T, Takahashi H, Takahashi H. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases\u2013associated interstitial lung disease and interstitial pneumonia with autoimmune features. PLoS ONE. 2020;15(11):e0241719.","journal-title":"PLoS ONE"},{"issue":"12","key":"4074_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11926-024-01155-8","volume":"26","author":"DIAD Sullivan","year":"2024","unstructured":"Sullivan DIAD. Rheumatoid arthritis-associated interstitial lung disease (RA-ILD): update on prevalence, risk factors, pathogenesis, and therapy. Curr Rheumatol Rep. 2024;26(12):431\u201349.","journal-title":"Curr Rheumatol Rep"},{"key":"4074_CR18","doi-asserted-by":"publisher","first-page":"1129939","DOI":"10.3389\/fmed.2023.1129939","volume":"10","author":"ATA Stainer","year":"2023","unstructured":"Stainer ATA, De Santis M, Amati F, Ceribelli A, Bongiovanni G, Torrisi C, et al. Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: a critical review. Front Med. 2023;10:1129939.","journal-title":"Front Med"},{"key":"4074_CR19","first-page":"1","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:1\u20139.","journal-title":"BMJ"},{"issue":"5","key":"4074_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232978","volume":"15","author":"J Avouac","year":"2020","unstructured":"Avouac J, Cauvet A, Steelandt A, Shirai Y, Elhai M, Kuwana M, et al. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease. PLoS ONE. 2020;15(5):e0232978.","journal-title":"PLoS ONE"},{"issue":"1","key":"4074_CR21","doi-asserted-by":"publisher","first-page":"9469","DOI":"10.1038\/s41598-022-13474-w","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Chen Y, Liu D, Lin Y, Zhu L, Song S, et al. Predictors of long-term prognosis in rheumatoid arthritis-related interstitial lung disease. Sci Rep. 2022;12(1):9469.","journal-title":"Sci Rep"},{"key":"4074_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112173","volume":"134","author":"Q Fang","year":"2024","unstructured":"Fang Q, Xie J, Zong J, Zhou Y, Zhou Q, Yin S, et al. Expression and diagnostic value of interleukin-22 in rheumatoid arthritis-associated interstitial lung disease. Int Immunopharmacol. 2024;134:112173.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"4074_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/1756-185X.14084","volume":"24","author":"MS Hussein","year":"2021","unstructured":"Hussein MS, El-Barbary AM, Nada DW, Gaber RA, Elkolaly RM, Aboelhawa MA. Identification of serum interleukin-13 and interleukin-13 receptor subunit expressions: rheumatoid arthritis\u2013associated interstitial lung disease. Int J Rheum Dis. 2021;24(4):591\u20138.","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"4074_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/art.41123","volume":"72","author":"DJ Kass","year":"2020","unstructured":"Kass DJ, Nouraie M, Glassberg MK, Ramreddy N, Fernandez K, Harlow L, et al. Comparative profiling of serum protein biomarkers in rheumatoid arthritis\u2013associated interstitial lung disease and idiopathic pulmonary fibrosis. Arthritis Rheumatol. 2020;72(3):409\u201319.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4074_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reuma.2023.05.001","volume":"20","author":"YS Makarem","year":"2024","unstructured":"Makarem YS, Ahmed EA, Makboul M, Farghaly S, Mostafa N, El Zohne RA, et al. CXCL10 as a biomarker of interstitial lung disease in patients with rheumatoid arthritis. Reumatol Cl\u00edn. 2024;20(1):1\u20137.","journal-title":"Reumatol Cl\u00edn"},{"issue":"2","key":"4074_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/03009742.2018.1477989","volume":"48","author":"T Matsuo","year":"2019","unstructured":"Matsuo T, Hashimoto M, Ito I, Kubo T, Uozumi R, Furu M, et al. Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study. Scand J Rheumatol. 2019;48(2):87\u201394.","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"4074_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076800","volume":"24","author":"N Mena-V\u00e1zquez","year":"2023","unstructured":"Mena-V\u00e1zquez N, Godoy-Navarrete FJ, Lisbona-Monta\u00f1ez JM, Redondo-Rodriguez R, Manrique-Arija S, Rioja J, et al. Inflammatory biomarkers in the diagnosis and prognosis of rheumatoid arthritis\u2013associated interstitial lung disease. Int J Mol Sci. 2023;24(7):6800.","journal-title":"Int J Mol Sci"},{"key":"4074_CR28","doi-asserted-by":"publisher","first-page":"1056121","DOI":"10.3389\/fmolb.2022.1056121","volume":"9","author":"V Pulito-Cueto","year":"2022","unstructured":"Pulito-Cueto V, Remuzgo-Mart\u00ednez S, Genre F, Atienza-Mateo B, Mora-Cuesta VM, Iturbe-Fern\u00e1ndez D, et al. Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis. Front Mol Biosci. 2022;9:1056121.","journal-title":"Front Mol Biosci"},{"issue":"6","key":"4074_CR29","first-page":"919","volume":"138","author":"H Shen","year":"2013","unstructured":"Shen H, Xia L, Lu J. Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study. Indian J Med Res. 2013;138(6):919\u201321.","journal-title":"Indian J Med Res"},{"issue":"1","key":"4074_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.55563\/clinexprheumatol\/mccyj0","volume":"40","author":"X Wang","year":"2022","unstructured":"Wang X, Zhu G, Ren Q, Wu J, Gu B, Su D, et al. Increased interleukin-11 associated with disease activity and development of interstitial lung disease in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2022;40(1):135\u201341.","journal-title":"Clin Exp Rheumatol"},{"key":"4074_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/art.43149","author":"AM Wheeler","year":"2025","unstructured":"Wheeler AM, Baker JF, Riley TR IV, Johnson TM, Yang Y, Roul P, et al. Peripheral biomarker signatures in rheumatoid arthritis\u2013associated interstitial lung disease. Arthritis Rheumatol. 2025. https:\/\/doi.org\/10.1002\/art.43149.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"4074_CR32","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1093\/rheumatology\/keae697","volume":"64","author":"TM Wilson","year":"2025","unstructured":"Wilson TM, Bolt M, Stahly A, Lee JS, Bang TJ, Sachs PB, et al. Transforming growth factor-beta is increased in sputum from individuals with rheumatoid arthritis-associated pulmonary fibrosis. Rheumatology. 2025;64(6):3989\u201395.","journal-title":"Rheumatology"},{"issue":"1","key":"4074_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cyto.2011.12.010","volume":"58","author":"Z Xiangyang","year":"2012","unstructured":"Xiangyang Z, Lutian Y, Lin Z, Liping X, Hui S, Jing L. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. Cytokine. 2012;58(1):6\u20139.","journal-title":"Cytokine"},{"issue":"1","key":"4074_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10753-022-01733-x","volume":"46","author":"W Zheng","year":"2023","unstructured":"Zheng W, Hu X, Zou M, Hu N, Song W, Wang R, et al. Plasma IL-36\u03b1 and IL-36\u03b3 as potential biomarkers in interstitial lung disease associated with rheumatoid arthritis: a pilot study in the Chinese population. Inflammation. 2023;46(1):285\u201396.","journal-title":"Inflammation"},{"key":"4074_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1160755","volume":"10","author":"JJG Sweis","year":"2023","unstructured":"Sweis JJG, Sweis NW, Alnaimat F, Jansz J, Liao T-WE, Alsakaty A, et al. Immune-mediated lung diseases: a narrative review. Front Med. 2023;10:1160755.","journal-title":"Front Med"},{"issue":"4","key":"4074_CR36","doi-asserted-by":"publisher","first-page":"L507","DOI":"10.1152\/ajplung.00263.2022","volume":"324","author":"CM Novak","year":"2023","unstructured":"Novak CM, Sethuraman S, Luikart KL, Reader BF, Wheat JS, Whitson B, et al. Alveolar macrophages drive lung fibroblast function in cocultures of IPF and normal patient samples. Am J Physiol Lung Cell Mol Physiol. 2023;324(4):L507\u201320.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"4074_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040897","volume":"10","author":"J-W Lee","year":"2021","unstructured":"Lee J-W, Chun W, Lee HJ, Min J-H, Kim S-M, Seo J-Y, et al. The role of macrophages in the development of acute and chronic inflammatory lung diseases. Cells. 2021;10(4):897.","journal-title":"Cells"},{"issue":"12","key":"4074_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.643149","volume":"11","author":"WJ Zhang","year":"2021","unstructured":"Zhang WJ, Chen SJ, Zhou SC, Wu SZ, Wang H. Inflammasomes and fibrosis. Front Immunol. 2021;11(12):643149.","journal-title":"Front Immunol"},{"issue":"3","key":"4074_CR39","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/biomedicines12030639","volume":"12","author":"M Lazar","year":"2024","unstructured":"Lazar M, Sandulescu M, Barbu EC, Chitu-Tisu CE, Andreescu DI, Anton AN, et al. The role of cytokines and molecular pathways in lung fibrosis following SARS-CoV-2 infection: a physiopathologic (re) view. Biomedicines. 2024;12(3):639.","journal-title":"Biomedicines"},{"key":"4074_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110264","volume":"265","author":"R Liu","year":"2024","unstructured":"Liu R, Wang F, Luo X, Yang F, Gao J, Shen H, et al. The immunomodulatory of interleukin-33 in rheumatoid arthritis: a systematic review. Clin Immunol. 2024;265:110264.","journal-title":"Clin Immunol"},{"issue":"14","key":"4074_CR41","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1016\/j.cell.2024.05.015","volume":"187","author":"M Kamiya","year":"2024","unstructured":"Kamiya M, Carter H, Espindola MS, Doyle TJ, Lee JS, Merriam LT, et al. Immune mechanisms in fibrotic interstitial lung disease. Cell. 2024;187(14):3506\u201330.","journal-title":"Cell"},{"issue":"1","key":"4074_CR42","doi-asserted-by":"publisher","first-page":"11131","DOI":"10.1038\/s41598-024-61269-y","volume":"14","author":"ZA Hussein","year":"2024","unstructured":"Hussein ZA, Abu-Raghif AR, Tahseen NJ, Rashed KA, Shaker NS, Fawzi HA. Vinpocetine alleviated alveolar epithelial cells injury in experimental pulmonary fibrosis by targeting PPAR-\u03b3\/NLRP3\/NF-\u03baB and TGF-\u03b21\/Smad2\/3 pathways. Sci Rep. 2024;14(1):11131.","journal-title":"Sci Rep"},{"issue":"585","key":"4074_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba2927","volume":"13","author":"FJ Li","year":"2021","unstructured":"Li FJ, Surolia R, Li H, Wang Z, Liu G, Kulkarni T, et al. Citrullinated vimentin mediates development and progression of lung fibrosis. Sci Transl Med. 2021;13(585):eaba2927.","journal-title":"Sci Transl Med"},{"issue":"10","key":"4074_CR44","doi-asserted-by":"publisher","first-page":"1160755","DOI":"10.3389\/fmed.2023.1160755","volume":"6","author":"JJ Sweis","year":"2023","unstructured":"Sweis JJ, Sweis NW, Alnaimat F, Jansz J, Liao TW, Alsakaty A, et al. Immune-mediated lung diseases: a narrative review. Front Med. 2023;6(10):1160755.","journal-title":"Front Med"},{"key":"4074_CR45","doi-asserted-by":"crossref","unstructured":"Bonella F, Costabel U. Biomarkers in connective tissue disease-associated interstitial lung disease. In: Seminars in respiratory and critical care medicine. Vol. 35, No. 02. Thieme Medical Publishers; 2014. pp. 181\u2013200.","DOI":"10.1055\/s-0034-1371527"},{"issue":"6","key":"4074_CR46","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/biomedicines13061463","volume":"13","author":"SW Chung","year":"2025","unstructured":"Chung SW. Predictive biomarkers and novel treatments for the progressive fibrosing phenotype in interstitial lung disease associated with connective tissue disease. Biomedicines. 2025;13(6):1463.","journal-title":"Biomedicines"},{"key":"4074_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/17534666241288417","volume":"18","author":"H Huang","year":"2024","unstructured":"Huang H, Wang Q, Xu Z. Advances in the identification and management of progressive pulmonary fibrosis: perspective from Chinese experts. Ther Adv Respir Dis. 2024;18:17534666241288417.","journal-title":"Ther Adv Respir Dis"},{"issue":"2","key":"4074_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088176","volume":"9","author":"X Cai","year":"2014","unstructured":"Cai X, Chen Z, Pan X, Xia L, Chen P, Yang Y, et al. Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1\/CXCR4 axis. PLoS ONE. 2014;9(2):e88176.","journal-title":"PLoS ONE"},{"issue":"1","key":"4074_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28404-y","volume":"8","author":"B Gao","year":"2018","unstructured":"Gao B, Lin J, Jiang Z, Yang Z, Yu H, Ding L, et al. Upregulation of chemokine CXCL10 enhances chronic pulmonary inflammation in tree shrew collagen-induced arthritis. Sci Rep. 2018;8(1):9993.","journal-title":"Sci Rep"},{"issue":"10","key":"4074_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13101715","volume":"13","author":"E Zanatta","year":"2023","unstructured":"Zanatta E, Martini A, Depascale R, Gamba A, Tonello M, Gatto M, et al. CCL18 as a biomarker of interstitial lung disease (ILD) and progressive fibrosing ILD in patients with idiopathic inflammatory myopathies. Diagnostics. 2023;13(10):1715.","journal-title":"Diagnostics"},{"issue":"10","key":"4074_CR51","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/thorax-2021-217822","volume":"77","author":"X Wu","year":"2022","unstructured":"Wu X, Jeong Y, de Fr\u00edas SP, Easthausen I, Hoffman K, Oromendia C, et al. Serum proteomic profiling of rheumatoid arthritis\u2013interstitial lung disease with a comparison to idiopathic pulmonary fibrosis. Thorax. 2022;77(10):1041\u20134.","journal-title":"Thorax"},{"issue":"1","key":"4074_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01856-z","volume":"22","author":"M Qiu","year":"2021","unstructured":"Qiu M, Jiang J, Nian X, Wang Y, Yu P, Song J, et al. Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Respir Res. 2021;22(1):264.","journal-title":"Respir Res"},{"issue":"2","key":"4074_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04126-3","volume":"79","author":"O Ciesielski","year":"2022","unstructured":"Ciesielski O, Biesiekierska M, Panthu B, Soszy\u0144ski M, Pirola L, Balcerczyk A. Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives. Cell Mol Life Sci. 2022;79(2):94.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"4074_CR54","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s40744-021-00362-4","volume":"8","author":"T Khan","year":"2021","unstructured":"Khan T, Jose RJ, Renzoni EA, Mouyis M. A closer look at the role of anti-CCP antibodies in the pathogenesis of rheumatoid arthritis-associated interstitial lung disease and bronchiectasis. Rheumatol Ther. 2021;8(4):1463\u201375.","journal-title":"Rheumatol Ther"},{"issue":"6","key":"4074_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286191","volume":"18","author":"M Zhang","year":"2023","unstructured":"Zhang M, Yin J, Zhang X. Factors associated with interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS ONE. 2023;18(6):e0286191.","journal-title":"PLoS ONE"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-04074-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04074-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04074-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:04:11Z","timestamp":1775574251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-04074-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4074"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-04074-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"505"}}